Becton Dickinson (BDX) Research & Development (2009 - 2026)
Becton Dickinson's (BDX) quarterly Research & Development came in at $249.0 million in Q1 2026, up 7.33% year-on-year from $232.0 million in Q1 2025, and down 18.63% on a QoQ basis from $306.0 million in Q4 2025.
Becton Dickinson (BDX) Research & Development (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Research & Development data on file, last reported at $249.0 million in Q1 2026.
- On a quarterly basis, Research & Development rose 7.33% year-over-year to $249.0 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 0.17% change from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 6.3% from the prior year.
- Research & Development for Q1 2026 stood at $249.0 million, down from $306.0 million in the prior quarter.
- Over the last five years, Research & Development for BDX reached as high as $343.0 million in Q4 2024 and fell as low as $232.0 million in Q1 2025.
- Historically, Research & Development has averaged $301.1 million across 5 years, with a median of $302.0 million in 2024.
- Across the five-year window, Research & Development climbed 18.28% in 2024 and slipped 22.41% in 2025, its largest moves.
- Year by year, Research & Development stood at $313.0 million in 2022, then fell by 7.35% to $290.0 million in 2023, then climbed by 18.28% to $343.0 million in 2024, then decreased by 10.79% to $306.0 million in 2025, then decreased by 18.63% to $249.0 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $249.0 million in Q1 2026, $306.0 million in Q4 2025, and $322.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 139.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.00 Mn |
| Dec 31, 2025 | 306.00 Mn |
| Sep 30, 2025 | 322.00 Mn |
| Jun 30, 2025 | 297.00 Mn |
| Mar 31, 2025 | 232.00 Mn |
| Dec 31, 2024 | 343.00 Mn |
| Sep 30, 2024 | 302.00 Mn |
| Jun 30, 2024 | 299.00 Mn |
| Mar 31, 2024 | 299.00 Mn |
| Dec 31, 2023 | 290.00 Mn |
| Sep 30, 2023 | 281.00 Mn |
| Jun 30, 2023 | 306.00 Mn |
| Mar 31, 2023 | 337.00 Mn |
| Dec 31, 2022 | 313.00 Mn |
| Sep 30, 2022 | 300.00 Mn |
| Jun 30, 2022 | 315.00 Mn |
| Mar 31, 2022 | 327.00 Mn |
| Dec 31, 2021 | 314.00 Mn |
| Sep 30, 2021 | 368.00 Mn |
| Jun 30, 2021 | 330.00 Mn |